Novo Nordisk

“Novo believes the personal injury lawsuits filed in the U.S. are without merit and we are defending them in court.”

Novo Nordisk · said date not stated · reported 2026-10-15

Novo Nordisk disputed that the medication causes NAION and stated the lawsuits are without merit.

“no difference between semaglutide 2.4 mg and placebo.”

Novo Nordisk · said date not stated · reported 2026-09-09

Novo Nordisk stated in its trials that there was no difference between semaglutide 2.4 mg and placebo in suicidal ideation or behavior.